Literature DB >> 28776583

Bone cancer: Is the osteosarcoma genome targetable?

Sharon A Savage1, Lisa Mirabello1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28776583     DOI： 10.1038/nrendo.2017.101

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  7 in total

1.  Chidamide augment sorafenib-derived anti-tumor activities in human osteosarcoma cells lines and xenograft mouse model.

Authors:  Ying Yuan; Daifeng Li; Xiang Hu; Yizhou Li; Wanrong Yi; Pengcheng Li; Yong Zhao; Zonghuan Li; Aiming Yu; Chao Jian; Aixi Yu
Journal:  Med Oncol       Date:  2022-04-28       Impact factor: 3.064

2.  Clinical significance of serum soluble B7-H3 in patients with osteosarcoma.

Authors:  Ling Wang; Fu-Biao Kang; Guo-Chuan Zhang; Juan Wang; Ming-Fang Xie; Ying-Ze Zhang
Journal:  Cancer Cell Int       Date:  2018-08-13       Impact factor: 5.722

3.  High SENP3 Expression Promotes Cell Migration, Invasion, and Proliferation by Modulating DNA Methylation of E-Cadherin in Osteosarcoma.

Authors:  Pu Yang; Yan Liu; Yin Chao Qi; Zhang Hong Lian
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

4.  The insertion and dysregulation of transposable elements in osteosarcoma and their association with patient event-free survival.

Authors:  Chao Wang; Chun Liang
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.996

Review 5.  Regulatory Role of N6-methyladenosine (m6A) Modification in Osteosarcoma.

Authors:  Yujie Zhang; Yanyan Wang; Liwei Ying; Sifeng Tao; Mingmin Shi; Peng Lin; Yangxin Wang; Bin Han
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

6.  Serum Antibodies Against Simian Virus 40 Large T Antigen, the Viral Oncoprotein, in Osteosarcoma Patients.

Authors:  Elisa Mazzoni; Ilaria Bononi; Maria S Benassi; Piero Picci; Elena Torreggiani; Marika Rossini; Andrea Simioli; Maria V Casali; Paola Rizzo; Mauro Tognon; Fernanda Martini
Journal:  Front Cell Dev Biol       Date:  2018-06-22

Review 7.  The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis.

Authors:  George N Tzanakakis; Eirini-Maria Giatagana; Aikaterini Berdiaki; Ioanna Spyridaki; Kyoko Hida; Monica Neagu; Aristidis M Tsatsakis; Dragana Nikitovic
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.